BioCentury
ARTICLE | Financial News

Catalyst Biosciences proposes follow-on

March 17, 2017 5:40 PM UTC

Hematology company Catalyst Biosciences Inc. (NASDAQ:CBIO) proposed to raise up to $12 million in a follow-on underwritten by Ladenburg Thalmann on March 13....

BCIQ Company Profiles

Catalyst Biosciences Inc.